Journal of Bacteriology · 1999 · 292 citations · 27 references
MedicineMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial ResistancePharmacodynamicsAntibacterial AgentsAntibacterial PharmacologyAntibacterial ResistanceEfflux-mediated ResistanceTuberculosis PharmacotherapyIntracellular Drug AccumulationIntracellular PersistenceIntrinsic Resistance In MycobacteriaIntrinsic Resistance In Mycobacterium TuberculosisMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisTuberculosis Drug Resistance
Pyrazinamide (PZA) is an important antituberculosis drug. Unlike most antibacterial agents, PZA, despite its remarkable in vivo activity, has no activity against Mycobacterium tuberculosis in vitro except at an acidic pH. M. tuberculosis is uniquely susceptible to PZA, but other mycobacteria as well as nonmycobacteria are intrinsically resistant. The role of acidic pH in PZA action and the basis for the unique PZA susceptibility of M. tuberculosis are unknown. We found that in M. tuberculosis, acidic pH enhanced the intracellular accumulation of pyrazinoic acid (POA), the active derivative of PZA, after conversion of PZA by pyrazinamidase. In contrast, at neutral or alkaline pH, POA was mainly found outside M. tuberculosis cells. PZA-resistant M. tuberculosis complex organisms did not convert PZA into POA. Unlike M. tuberculosis, intrinsically PZA-resistant M. smegmatis converted PZA into POA, but it did not accumulate POA even at an acidic pH, due to a very active POA efflux mechanism. We propose that a deficient POA efflux mechanism underlies the unique susceptibility of M. tuberculosis to PZA and that the natural PZA resistance of M. smegmatis is due to a highly active efflux pump. These findings may have implications with regard to the design of new antimycobacterial drugs.
27
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Ying Zhang, Béate Heym, Douglas B. Young et al. · Nature · 1992 · 1.3K citations · Full text
The action of antituberculosis drugs in short-course chemotherapy
D.A. Mitchison · Tubercle · 1985 · 512 citations
Active efflux of bile salts by Escherichia coli
David G. Thanassi, Lu Cheng, Hiroshi Nikaido · Journal of Bacteriology · 1997 · 473 citations